ReviewBMC medicine2013
Advances in bladder cancer imaging.
Review in BMC medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 89 citations in OpenAlex.
- Mapping Local Failure Following Bladder Radiotherapy According to Dose.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2022Trial
- Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects.The Canadian journal of urology · 2026Review
- Artificial intelligence-assisted diagnosis and histopathological grading of bladder cancer: current status, challenges, and future directions.Frontiers in digital health · 2026Review
- Magnetic Resonance Imaging Sequences and Technologies in Adaptive Radiation Therapy.International journal of radiation oncology, biology, physics · 2025Review
- Assessment of pathological grade and variants of bladder cancer with a continuous-time random-walk diffusion model.Frontiers in oncology · 2024Article
- Magnetic resonance radiographic features which might lead to misdiagnosis of muscle-invasive bladder cancer based on vesical imaging reporting and data system: the application experience of a single center.Quantitative imaging in medicine and surgery · 2023Article
- Multiparametric magnetic resonance imaging of plasmacytoid urothelial carcinoma with histopathological correlation: A case report.Radiology case reports · 2022Article
- The role of radiomics with machine learning in the prediction of muscle-invasive bladder cancer: A mini review.Frontiers in oncology · 2022Review
- Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy.Frontiers in oncology · 2022Article
- Application of nanotechnology in the diagnosis and treatment of bladder cancer.Journal of nanobiotechnology · 2021Review
- MR-Guided Adaptive Radiotherapy for Bladder Cancer.Frontiers in oncology · 2021Review
- Organ preservation in bladder cancer: an opportunity for truly personalized treatment.Nature reviews. Urology · 2019Review
- Hope and challenge: Precision medicine in bladder cancer.Cancer medicine · 2019Review
- Role of Diffusion-Weighted Magnetic Resonance Imaging (DWMRI) in Assessment of Primary Penile Tumor Characteristics and Its Correlations With Inguinal Lymph Node Metastasis: A Prospective Study.World journal of oncology · 2018Article
- Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.Translational andrology and urology · 2018Review
- Behavior of blood plasma glycan features in bladder cancer.PloS one · 2018Article
- Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.Journal of magnetic resonance imaging : JMRI · 2017Article
- Advances in Imaging in Prostate and Bladder Cancer.Current urology reports · 2017Review
- Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.Clinical nuclear medicine · 2017Article
- Clinical experience of MRI in two dogs with muscle-invasive transitional cell carcinoma of the urinary bladder.The Journal of veterinary medical science · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The purpose of this article is to review the imaging techniques that have changed and are anticipated to change bladder cancer evaluation. The use of multidetector 64-slice computed tomography (CT) and magnetic resonance imaging (MRI) remain standard staging modalities. The development of functional imaging such as dynamic contrast-enhanced MRI, diffusion-weighted MRI and positron emission tomography (PET)-CT allows characterization of tumor physiology and potential genotypic activity, to help stratify and inform future patient management. They open up the possibility of tumor mapping and individualized treatment solutions, permitting early identification of response and allowing timely change in treatment. Further validation of these methods is required however, and at present they are used in conjunction with, rather than as an alternative to, conventional imaging techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.